News

New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
The surprising role lizard venom played in inventing Ozempic — as FDA warns about fakes being sold
The Gila monster is a large, magnificent, and venomous desert-dwelling reptile found throughout the southwestern US and Mexico. A toxic bite from the Gila can cause searing pain, loss of consciousness ...
News-Medical.Net on MSN9d
Semaglutide linked to higher risk of vision problems, FDA data analysis shows
Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...
Kentucky Today1d
Ashland doctor pleads guilty to receiving, selling unapproved semaglutide
An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...
The GLP-1 drug shortage is over. What’s next for the compounders?
Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
Kentucky doctor admits providing non-approved drug to weight-loss patients
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
Marti Law Group Files Amicus Brief on Behalf of NP2Go in Federal Suit Challenging FDA's Removal of Semaglutide From Drug Shortage List
WEST HARTFORD, CONNECTICUT / ACCESS Newswire / April 11, 2025 / Marti Law Group has filed an amicus curiae brief in the U.S.